SCHEMBL7744057

SCHEMBL7744057

CCCCC(=O)Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
ADORA1 P30542 4/20 0.42
ADORA2A P29274 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 3/20 0.41
MAPT P10636 4/20 0.40
LMNA P02545 3/20 0.40
ADORA3 P0DMS8 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739024 0.89 KDR (0.50) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7744076 0.87 KDR (0.46) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7744200 0.86 KDR (0.53) ADORA2AMEN1KMT2AKDM4EALDH1A1
SCHEMBL7744044 0.85 HPGD (0.44) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7744165 0.85 HPGD (0.44) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7744194 0.85 ADORA1 (0.46) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7744660 0.85 KDR (0.44) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7746631 0.84 KDR (0.42) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7744655 0.84 HPGD (0.50) HPGDSMN1; SMN2NPSR1USP2TSHR
SCHEMBL7739010 0.83 KDR (0.47) HPGDSMN1; SMN2NPSR1USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed